Vitamin d deficiency with high parathyroid hormone levels is related to late onset SEPSIS among preterm infants.

Preterm infants (PTs) are at greater risk for vitamin D deficiency, which relates to the possibility of a higher incidence of comorbidities. Our goal was twofold, 1) to monitor vitamin D, calcium, phosphorus, parathyroid hormone (PTH), matrix metalloproteinase-8 (MMP-8) serum levels at three-time points during hospitalization, and 2) to assess the association between 25-hydroxyvitamin D (25OHD) levels and outcomes in PTs. METHODS: We carried out a follow-up on 50 Caucasian PTs ≤ 32 weeks of gestational age (GA) and/or ≤ 1500 g birth weight at 28 days and at 4 months. PTs were divided into two subgroups for tests of association with clinical outcomes based on vitamin D deficient infants 25(OH) D cord blood levels: ≤ 20 ng/ml). At an initial stage, 25(OH) D levels were determined in maternal/preterm blood samples and were compared to full term delivery infants. RESULTS: There were no differences in 25(OH) D serum levels at birth when comparing PTs to term infants, or regarding maternal levels. A strong positive correlation was detected between maternal and neonatal 25(OH) D serum levels among PTs and term infants (r: 0.466; p < 0.001). Neonates with vitamin D deficiency did not present a higher incidence of comorbidities. PTs were classified in two subgroups based on vitamin D and PTH (group 1: vitamin D < 20 ng/mL and PTH > 60 pg/mL; group 2: vitamin D > 20 and PTH < 60 pg/mL). The PTs in group 1 showed a higher incidence of LOS (RR: 2; 95% CI: 1.31-3.55). No relationship was observed between MMP-8 serum levels and the incidence of sepsis. CONCLUSIONS: This study did not find any evidence of an increase in preterm birth risk related to vitamin D level at birth. Vitamin D deficiency by itself is not associated with a higher incidence of comorbidities. However, the binomial vitamin D-PTH must be taken into consideration.

Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital.

INTRODUCTION: Neuromuscular diseases include a large group of heterogeneous and rare pathologies that affect different components of the motor unit. It is essential to optimize resources to know the prevalence of comorbidities in the most frequent groups to establish an early multidisciplinary approach in a specialized setting. PATIENTS AND METHODS: Retrospective descriptive study of pediatric and adolescent patients with neuromuscular diseases (NMDs). The Inclusion criteria were NMDs patients with motor neuron involvement divided into three groups, depending on the affected component of the motor unit. Group I: involvement of the motor neuron; Group II: peripheral neuropathies; Group III: myopathies. Demographic variables, association with comorbidities, need for respiratory support, and rehabilitative treatment were collected in each group. RESULTS: Ninety-six patients who met the inclusion criteria were studied. In group I, when compared to the other two groups, a higher incidence of scoliosis (68.3%, p = 0.011), deformity of the rib cage (31.3%, p = 0.0001), chronic respiratory insufficiency (62.5%, p = 0.001) and bronchial aspiration (12.5%, p = 0.03) was detected. In this group, 50%of the patients required non-invasive mechanical ventilation (p = 0.0001). The in-hospital requirement for respiratory physiotherapy was higher in group I (75%, p = 0.001). We observed a higher incidence of scoliosis in Group III compared to Group II. CONCLUSIONS: Neuromuscular diseases with motor neuron involvement present more comorbidities and require an early approach after diagnosis to improve prognosis.

Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.

INTRODUCTION: It is challenging to establish the mechanisms involved in the variety of well-defined clinical phenotypes in autism spectrum disorder (ASD) and the pathways involved in their pathogeneses. OBJECTIVES: The aim of the present study was to evaluate the metabolomic profiles of children with ASD subclassified by mental regression (AR) phenotype and with no regression (ANR). METHODS: The present study was a cross-sectional case-control study. Thirty children aged 2-6 years with ASD were included: 15 with ANR and 15 with AR. In addition, a control group of 30 normally developing children was selected and matched to the ASD group by sex and age. Plasma samples were analyzed with a metabolomics single platform methodology based on liquid chromatography-mass spectrometry. Univariate and multivariate analysis, including orthogonal partial least squares-discriminant analysis modeling and Shared-and-Unique-Structures plots, were performed using MetaboAnalyst 4.0 and SIMCA-P 15. The primary endpoint was the metabolic signature profiling among healthy children and autistic children and their subgroups. RESULTS: Metabolomic profiles of 30 healthy children, 15 ANR and 15 AR were compared. Several differences between healthy children and children with ASD were detected, involving mainly amino acid, lipid and nicotinamide metabolism. Furthermore, we report subtle differences between the ANR and AR groups. CONCLUSIONS: In this study, we report, for the first time, the plasmatic metabolomic profiles of children with ASD, including two different phenotypes based on mental regression status. The use of a liquid chromatography-mass spectrometry platform approach for metabolomics in ASD children using plasma appears to be very efficient and adds further support to previous findings in urine. Furthermore, the present study documents several changes related to amino acid, NAD+ and lipid metabolism that, in some cases, such as arginine and glutamate pathway alterations, seem to be associated with the AR phenotype. Further targeted analyses are needed in a larger cohort to validate the results presented herein.

Evaluation of the vasoactive-inotropic score, mid-regional pro-adrenomedullin and cardiac troponin I as predictors of low cardiac output syndrome in children after congenital heart disease surgery.

OBJECTIVE: To determine the predictive value of the inotropic score (IS) and vasoactive-inotropic score (VIS) in low cardiac output syndrome (LCOS) in children after congenital heart disease surgery involving cardiopulmonary bypass (CPB), and to establish whether mid-regional pro-adrenomedullin (MR-proADM) and cardiac troponin I (cTn-I), associated to the IS and VIS scores, increases the predictive capacity in LCOS. DESIGN: A prospective observational study was carried out. SETTING: A Paediatric Intensive Care Unit. PATIENTS: A total of 117children with congenital heart disease underwent CPB. Patients were divided into two groups: LCOS and non-LCOS. INTERVENTIONS: The clinical and analytical data were recorded at 2, 12, 24 and 48h post-CPB. Logistic regression was used to develop a risk prediction model using LCOS as dependent variable. MAIN OUTCOME MEASURES: LCOS, IS, VIS, MR-proADM, cTn-I, age, sex, CPB time, PIM-2, Aristotle score. RESULTS: While statistical significance was not recorded for IS in the multivariate analysis, VIS was seen to be independently associated to LCOS. On the other hand, VIS>15.5 at 2h post-CPB, adjusted for age and CPB timepoints, showed high specificity (92.87%; 95%CI: 86.75-98.96) and increased negative predictive value (75.59%, 95%CI: 71.1-88.08) for the diagnosis of LCOS at 48h post-CPB. The predictive power for LCOS did not increase when VIS was combined with cTn-I >14ng/ml at 2h and MR-proADM >1.5nmol/l at 24h post-CPB. CONCLUSIONS: The VIS score at 2h post-CPB was identified as an independent early predictor of LCOS. This predictive value was not increased when associated with LCOS cardiac biomarkers. The VIS score was more useful than IS post-CPB in making early therapeutic decisions in clinical practice post-CPB.

Analysis of the local and systemic inflammatory response in hospitalized infants with respiratory syncitial virus bronchiolitis.

BACKGROUND: Respiratory syncytial virus acute bronchiolitis (RSV-AB) is a major cause of hospital admission among our infants. The immune and inflammatory mechanisms involved in the RSV-AB and factors influencing severity have not been clearly established, although an imbalanced Th1 and Th2 response seems to be crucial. OBJECTIVES: To assess the local and systemic inflammatory response in RSV-AB. To find a possible marker of clinical severity and/or oxygen requirements. PATIENTS AND METHODS: Levels of nine cytokines were measured in nasopharyngeal aspirate (NPA) and peripheral blood (PB) of 45 infants with RSV-AB and 27 peer controls, including IFNγ, TNFα, VEGF, interleukins 4, 6 and 10, and chemokines (IL-8 and macrophage inflammatory proteins 1-α and 1-ß). RESULTS: The levels of the analyzed cytokines and chemokines were significantly higher in the NPA of RSV-AB group, with a decrease in IL-4/IFNγ ratio. IL-6 and MIP-1ß levels in NPA were directly correlated to oxygen therapy. PB showed an increase in IL-8 and a decrease in MIP-1α and MIP-1ß in the RSV-AB group (only MIP-1ß associated to the need for oxygen therapy). No correlation was found between cytokines and chemokines levels in NPA and PB. CONCLUSIONS: This study shows that RSV triggers an inflammatory response fundamentally at the respiratory level, with scant systemic repercussion. This local response is characterized by an increase in Th1 and Th2 cytokines, although with a relative predominance of Th1. The determination upon patient admission of IL-6 and MIP-1ß levels in NPA, and of MIP-1ß in PB could help predict severe forms and the need for oxygenotherapy.

[Recommendations for the perinatal management and follow up of late preterm newborns]. / Recomendaciones para el manejo perinatal y seguimiento del recién nacido prematuro tardío.

Prematurity is the main reason for neonatal morbidity and mortality, and has become one of the greatest problems in public health, especially in developed countries. Prematurity rate has increased during the last 2 decades. This increase may be attributed to late preterm babies, that is, those with a gestational age between 34(+0) and 36(+6) weeks. Perinatal morbidities, as well as long term complications, are more frequent in this population than in term babies. The incidence is more similar to the one observed in earlier premature babies. The SEN34-36 group of the Spanish Society of Neonatology suggests these recommendations for the management of late preterm babies. Strategies are offered not only for the early detection of possible complications, but also for the correction of these morbidities, and from the point of view of a family and development centered care. Follow up is strongly recommended due to the high rate of late morbidities.

[Correspondence between the fatty acids in healthy children serum and in membrane phospholipids]. / Relación entre los ácidos grasos en suero y en los fosfolípidos de membrana en niños sanos.

INTRODUCTION: The diet is important in the supply of fatty acids in humans, especially those of the n-3 and n-6 families by its essentiality and related physiological function. It is important to have reference values in accessible biological samples: serum and erythrocyte membranes, in order to alleviate potential shortfalls. The objective is quantifying fatty acids present in these samples from C6 to C26. MATERIAL AND METHODS: the determinations of the fatty acids of 30 healthy children in serum and its corresponding membrane phospholipids from blood cells by lipid extraction, methylation, separation and quantification in gas chromatography with detection of masses have been. It is comparing the values obtained in each serum and its partner of cell membranes. RESULTS AND DISCUSSION: It is have obtained normal values in healthy children. The C16, which represent a quarter of all fatty acids, it is in the same proportion in both samples, in the rest of fatty acids, there is no clear correspondence between both values. In the n-6 family, the C18:2n6 is higher in serum against the C20:4n6 which is in the phospholipids. In the same way between the n-3 family, the C20:5n3 is higher in serum and the C22:6n3 is in membrane phospholipids. These values are cause of different processes, recent nutritional contribution to serum and with long-term implications and metabolic values in the phospholipids of membranes.

Introducción: La dieta es importante para el suministro de ácidos grasos del hombre, en especial los de las familias n-3 y n-6, por su esencialidad y las amplias funciones fisiológicas relacionadas. Es importante tener valores de referencia en las muestras biológicas accesibles, tales como suero y membranas eritrocitarias, con el fin de paliar posibles déficit. El objetivo del presente trabajo consiste en cuantificar los ácidos grasos esenciales (AGE) presentes en dichas muestras, desde la C6 hasta la C26. Material y métodos: Se han efectuado las determinaciones de los ácidos grasos de 30 niños sanos en suero y en sus correspondientes fosfolípidos de membrana de células sanguíneas, mediante su extracción lipídica, metilación, separación y cuantificación en cromatografía de gases con detección de masas. Se han comparado los valores obtenidos en cada suero y su pareja de membranas celulares. Resultados y discusión: Se han obtenido los valores normales en niños sanos. El C16, que supone la cuarta parte de todos los ácidos grasos, está en la misma proporción en ambas muestras; entre el resto, no se encuentra una correspondencia clara entre ambos valores. Entre los n-6, el C18:2n6 está en mayor proporción en suero, frente al C20:4n6 que lo está en los fosfolípidos. De igual forma, entre los n-3, el C20:5n3 está en mayor proporción en suero y el C22:6n3 lo está en fosfolípidos de membrana. Dichos valores son la causa de procesos distintos, aporte nutricional reciente para el suero y con implicaciones a largo plazo y metabólicas los valores en los fosfolípidos de las membranas.

Effects of parenteral nutrition formulas on plasma lipid profile in children with bone marrow transplantation.

BACKGROUND/AIMS: Children undergoing bone marrow transplantation (BMT) often require parenteral nutrition (PN). This is a comparative study of plasma lipid profiles in BMT children after fish oil or soybean PN. METHODS: A total of 14 children with BMT requiring PN for at least 10 days were recruited during 24 months. They were randomized to receive a lipid emulsion enriched with ω3 polyunsaturated fatty acid, or soybean oil. Clinical monitoring was performed. Blood samples were collected before and after administration of PN to analyze the lipid profile. RESULTS: There were no complications associated with PN. The increase in TG levels was more pronounced after administration of an enriched ω3 emulsion and the decrease in cHDL and apo A was greater after administration of soybean. The ω3 group showed an increase in eicosapentaenoic and a decrease in arachidonic acids compared to the soybean group. Both groups showed similar levels of linolenic acid. CONCLUSION: PN with soybean or ω3 emulsions for 10 days is safe in children. However, research in children are necessary in order to examine the impact of the duration of PN and the type of lipid formula used, and determine their health benefits in relation to the fatty acid profile.

[Trans fatty acids in the nutrition of children with neurological disorders]. / Ácidos grasos trans en la nutrición de niños con trastornos neurológicos.

INTRODUCTION: Trans-fatty acids are present in various foods, being the only source of the same in humans. Its presence in high concentrations is a risk factor for health, being involved in a series of events, cardiovascular, inflammatory, etc. Therefore, steps have been taken for its decrease in the diet. The aim is to determine serum and phospholipids of membranes in healthy children and neurological alterations. MATERIAL AND METHODS: It has analyzed the fatty acids trans in 34 healthy children and 374 with various neurological pathologies. Serum and blood cells, making the lipid extraction, samples have been separation of the phospholipids of cells membranes, methylation of fatty acids, separation by gas chromatography and quantification using mass detector. The data have been processed statistically. RESULTS: The distribution of trans fatty acids and their sum is not normally distributed, so its nonparemetric tests were used. The values are higher than in serum phospholipids and membrane with a weak but significant correlation. The tC18: 1 is in a double proportion in children with neurological disorders in healthy children, both in serum and membrane phospholipids, with significant differences. DISCUSSION: The highest proportion of trans-fatty acids in the group of children with neurological disorders is caused no doubt by an increase in intake, due to less adequate food.

Introducción: Los ácidos grasos trans (AGT) están presentes en diversos alimentos, y son la única fuente de los mismos en humanos. Su presencia en concentraciones elevadas supone un factor de riesgo para la salud, por lo que se ven implicados en toda una serie de eventos cardiovasculares, inflamatorios, etc. Por ello, se han adoptado medidas para su disminución en la dieta. Como objetivo, se pretende determinarlos en el suero y en los fosfolípidos de las membranas, tanto en los niños sanos, como en los que padecen alteraciones neurológicas. Material y métodos: Se han analizado los AGT de 34 niños sanos y de 374 con diversas patologías neurológicas. Se han utilizado muestras de suero y de células sanguíneas, para lo que se lleva a cabo una extracción lipídica, con separación de los fosfolípidos de las membranas de las células, metilación de los ácidos grasos, separación mediante cromatografía de gases y, finalmente, cuantificación mediante detector de masas. Los datos han sido procesados estadísticamente. Resultados: La distribución de los AGT y su suma no tienen una distribución normal, por lo que se han efectuado pruebas no paramétricas. Los valores son mayores en suero que en los fosfolípidos de membrana y con una correlación débil, aunque significativa. El tC18:1 tiene una proporción doble en los niños con trastornos neurológicos, frente a los niños sanos, tanto en el suero como en los fosfolípidos de membrana, con diferencias significativas. Discusión: La mayor proporción de AGT en el grupo de niños con trastornos neurológicos está causada, sin duda, por un incremento en su ingesta, lo que se debe a una alimentación menos adecuada.

[High ratio of omega 6/omega 3 ratio children with neuropathies; cause or effect]. / Índice elevado de ácidos grasos omega 6/omega3 en niños con neuropatía; causa o efecto.

INTRODUCTION: The n-3 and n-6 fatty acids compete for the same elongases and desaturases, still highly deficient synthesis of polyunsaturated fatty acids from n-3 linolenic acid. The n-3 polyunsaturated prevent disease and are important in the development and maintenance of neuronal activities, necessitating a proper relationship with their antagonists n-6. This paper studies the proportion of these fatty acids. MATERIAL AND METHODS: We analyzed the fatty acids of n- 3 and n-6 in sera and membrane phospholipid with 374 children neuropathies and 34 healthy children, using gas chromatography with mass detector. It has made the relevant statistical study. RESULTS: The n-3 (EPA and DHA) in serum and their corresponding membrane phospholipids correlate better than the n-6 family. The major n-6 (LA and ARA) are equally in serum, being significantly higher in phospholipids of healthy children. The n-3 (EPA and DHA) have higher values in healthy children, both in serum and phospholipids, their sum is equal to the membrane phospholipids. The n-6/n-3 ratio is higher in children with neurological disorder in both samples. CONCLUSION: Not being the cause of the high rate n-6/n- 3 neuropathy, however it is advisable to increase the intake of n-3, DHA particularly across the population, especially in children with neurological disorders.

Introducción: Los ácidos grasos n-3 y n-6 compiten por las mismas elongasas y desaturasas, siendo muy deficiente la síntesis de ácidos grasos poliinsaturados n-3 a partir de ácido linolénico. Los poliinsaturados n-3 previenen enfermedades y son importantes en el desarrollo y mantenimiento de las actividades neuronales, siendo necesaria una relación adecuada con sus antagonistas n- 6. En este trabajo se estudia la proporción de estos ácidos grasos. Material y métodos: Se han analizado los ácidos grasos n-3 y n-6 en sueros y fosfolípidos de membrana de 374 niños con neuropatías y de 34 niños sanos, mediante cromatografía de gases con detector de masas. Se ha realizado el estudio estadístico pertinente. Resultados: Los ácidos grasos n-3 (EPA y DHA) en suero y su correspondientes fosfolípidos de membrana correlacionan mejor que los de la familia n-6. Los mayoritarios n-6 (LA y ARA) están en igual proporción en sueros, siendo más elevados significativamente en los fosfolípidos de los niños sanos. Los n-3 (EPA y DHA) tienen valores más altos en los niños sanos, tanto en suero como en fosfolípidos, su suma se iguala en los fosfolípidos de membrana. El índice n-6/n-3 es mayor en los niños con trastorno neurológico en ambas muestras. Conclusión: No siendo la causa de la neuropatía el alto índice n-6/n-3, sin embargo es aconsejable incrementar la ingesta de n-3, sobre todo DHA en toda la población y en especial en los niños con trastornos neurológicos.

[Plasma fatty acids profile in paediatric cancer patients]. / Perfil de ácidos grasos en pacientes oncológicos pediátricos.

UNLABELLED: The small number of cases of cancer in children and the difficulties of research, have contributed to there being few studies on the metabolic and nutritional status of these patients. The main objective of this study was to investigate the nutritional and metabolic alterations in children with cancer, and specifically the plasma fatty acid profile after receiving chemotherapy, compared with a group of healthy children. METHODS: We selected 12 children with cancer aged between 0 and 16, who had received at least one cycle of chemotherapy, one month before the study and were not end-stage disease. Nutritional survey was conducted, anthropometric measurements, general biochemical analysis and profile of fatty acids in plasma were evaluated. RESULTS: No changes in anthropometric and nutritional biochemical parameters were detected. In the omega-6 fatty acids, lower values of linoleic and docosapentaenoic acid, and higher levels of gamma-linolenic acid, and normal levels of arachidonic acid were observed. In the omega-3, we found normal values of alpha-linolenic acid and docohexanoic acid, and lower values of eicosapentaenoic acid. CONCLUSION: It seems glimpsed a partial deficiency in the metabolism of polyunsaturated fatty acids in children with cancer, good nutrition and having received at least one cycle of chemotherapy. Further research is needed to allow specific supplementations.

Factor structure and psychometric properties of the center for epidemiologic studies depression scale (CES-D) in older populations with and without cognitive impairment.

The CES-D is widely used for the assessment of depressive symptoms in the adult population. However, few studies have been performed to assess the utility of this scale in an older population with cognitive impairment. The factor structure of the Spanish version of the CES-D was examined in an observational, cross sectional study in 623 older adults (M = 72.74 years; SD = 7.7). The validity of the scale was determined in two samples of older adults, one comprising 162 participants with cognitive impairment (M = 76.73 years; SD = 8.1) and one with 58 participants without cognitive impairment (M = 74.64 years; SD = 9.0). The results confirm previous results of a four factor structure. With regard to the validity of the scale, in the group with cognitive impairment the area under the ROC curve is 0.84 (95% CI: 0.77-0.89) and the cut-off point for possible depression is 13, while in the group without cognitive impairment the area is 0.90 (95% CI: 0.79-0.96) and the optimal cut-off point is 28. These results show that the Spanish version of the CES-D is a valid instrument for the identification of depression in older adults with and without cognitive impairment.

Atención Primaria e incontinencia urinariamasculina / No disponible

Evaluar los beneficios de la aplicación de un plan de cuidados específico en hombres con incontinencia urinaria ya sea de esfuerzo,urgencia o mixta y de grado leve o moderado. Estudio observacional longitudinal prospectivo, muestra de 21 pacientes Áreas SanitariasVII, VIII y XI Atención Primaria Comunidad de Madrid, seleccionados de forma aleatoria con etiqueta diagnóstica incontinencia urinaria,evaluando las intervenciones y los patrones funcionales interrelacionados. Herramienta informática AP MADRID y OMI-AP. Metodologíaenfermera con valoración según patrones funcionales de Marjory Gordon y Taxonomías NANDA-NOC-NIC. La aplicación «dirigida»del plan de cuidados individualizado mejora la calidad de vida (CV, cuestionario I-QoL) y sus procesos interrelacionados (AU)

Aim: evaluating benefits from the application of a care plan specify in men with urinary incontinence either of effort, urgency or mixedand of slight or moderate degree. Prospective longitudinal observable study, sample of 21 patient Sanitary Areas VII, VIII and XI PrimaryCare Madrid, selected randomly with diagnostic label Urinary Incontinence, evaluating interventions and interrelated functional patterns.Computer tool AP MADRID and OMI-AP. Nursing methodology with valuation according to functional patterns of Marjory Gordon andNANDA-NOC-NIC Taxonomies. The «directed» application of the individualized care improves life quality (CV, questionnaire I-QoL) andits interrelated processes (AU)

[Risk factors involved in the need for blood transfusion in very low birth weight newborns treated with erythropoietin]. / Factores de riesgo implicados en la necesidad de transfusión sanguínea en recién nacidos de muy bajo peso tratados con eritropoyetina.

OBJECTIVE: To identify and quantify risk factors related to red blood cell transfusion in premature babies weighing<1,500g who received erythropoietin (EPO). Secondly, to assess the relationship between retinopathy of prematurity and rh-EPO. MATERIAL AND METHODS: Prospective descriptive study of infants admitted to the Reina Sofía University Hospital between January 2006 and March 2009. Infants reviewed had a birth weight<1,500g and gestational age<32 weeks. Infants were administered rh-EPO 750IU/kg/week subcutaneously 3 days/week/ 6 weeks. We used univariate and multivariate logistic regressions with PASW Statistics 18 for Windows. RESULTS: Data were obtained from 110 infants, with a mean birth weight of 1154grs and mean gestational age of 29.3 weeks. Risk factors (OR; 95% CI) for being transfused were: male sex (4.41; 1.24-15.66), GA (1.64; 1.14-2.36, 1 week), Hb level on admission (1.45; 1.04-2.04; 1g/dl), late onset sepsis (7.75; 2.21-21.11), late onset treatment with rh-EPO (6.27; 1.22-32.35). All surgically treated infants with patent ductus arteriosus ligation or necrotizing enterocolitis needed transfusion. There is no relationship between rh-EPO administration and retinopathy of prematurity (ROP), but there was a relationship with transfusion. CONCLUSIONS: Premature infants with the lower gestational age, being male, a lower Hb level on admission and late onset sepsis are those with the greatest risk for blood transfusion.

[Glatiramer acetate in interferon beta non respondent relapsing-remitting multiple sclerosis]. / Acetato de glatiramero en pacientes con esclerosis múltiple remitente-recurrente no respondedores al interferón beta.

INTRODUCTION AND OBJECTIVE: There are 4 immunomodulator treatments approved as first line therapy for patients with re-lapsing-remitting multiple sclerosis (RRMS). The objective of this study is to assess if glatiramer acetate (GA) is useful or not in patients who have discontinued interferon beta due to a suboptimal response or adverse events. METHODS: This is an observational and retrospective study in RRMS patients who discontinued IFN-beta therapy (2.9+/-2.4 years of treatment) and switched to GA (1.9+/-1.4 years). They were classified in 2 groups depending on the reason for discontinuation: suboptimal response or side effects. In both treatments we analysed number of relapses, treatment duration and causes of discontinuation. RESULTS: We included 58 patients of which 20 discontinued IFN-beta for lack of effectiveness whereas 38 were due to adverse events. Patients who discontinued for suboptimal response changed from 1.38 +/- 0.95 relapses per year with IFN-beta to 0.52+/-0.86 with GA. Patients who discontinued for adverse events changed from 0.33 +/- 0.64 relapses per year with IFN-beta to 0.37+/-0.79 with GA. CONCLUSIONS: GA can be considered a good alternative treatment for MS patients with a suboptimal response or adverse events with IFN-beta which confirms the existence of different mechanisms of action in both drugs.

Enfermería en la incontinenciaurinaria y úlceras por presión / No disponible

La humedad de la piel derivada de la incontinencia urinaria, se ha relacionado con las úlceras por presión, figurando además, en las escalas de valoración como factor de riesgo. Los cuidados de enfermería preventivos relacionados con la incontinencia urinaria y sus efectos sobre la integridad de la piel influyen directamente en la evolución de las úlceras por presión en pacientes inmovilizados tanto a nivel hospitalario como a nivel domiciliario (AU)

The humidity of the skin derived from urinary incontinence has been related to pressure ulcers, appearing, besides, in the valuationscales as a risk factor. Preventive nursing cares that are related with urinary incontinence and its effects on the integrity of the skin aredirectly influential in the evolution of pressure ulcers in immobilized patients at hospital level as well as at residence level (AU)

Plan de cuidados incontinencia urinaria de esfuerzo / No disponible

No disponible

Nefritis intersticial aguda por omeprazol. A propósito de un caso / Omeprazole induced acute interstitial nephritis. A case report

La nefritis intersticial aguda es una importante causa de fallo renal agudo reversible (1-3% de éstos). En la mayoría de las ocasiones está causada por fármacos, siendo los antiinflamatorios, las penicilinas y las sulfonamidas los más frecuentemente implicados en la actualidad. Las manifestaciones clínicas de la nefritis intersticial aguda han variado con el paso del tiempo y con el uso masivo de nuevos fármacos. El omeprazol es un inhibidor de la bomba de protones prescrito ampliamente para el tratamiento del reflujo gastroesofágico y de la úlcera péptica. Aunque el omeprazol es generalmente bien tolerado, puede producir efectos adversos importantes como fallo renal agudo por nefritis intersticial. A continuación presentamos el caso de un paciente que presenta nefritis intersticial aguda secundaria a la toma de omeprazol

Acute interstitial nephritis is an important cause of acute, reversible renal failure (1%-3% of these). Most of them are due to drugs, the most frequently involved at present being anti-inflammatory drugs penicillins and sulfonamides. The clinical manifestations of acute interstitial nephritis have varied over time and with the massive use of new drugs. Omeprazole is a proton pump inhibitor that has been widely described for the treatment of gastroesophageal reflux and peptic ulcer. Although omeprazole is generally well tolerated, it may produce serious side effects such as acute renal failure due to interstitial nephritis. In the following, we present the case of a patient who had acute interstitial nephritis secondary to taking omeprazole

Profilaxis de la anemia de la prematuridad con eritropoyetina. Estudio caso-control / Prophylaxis of anemia of prematurity with erythropoietin. Case control study

OBJETIVO: PACIENTES Y MÉTODOS: Estudio de casos y controles, no aleatorizado, retrospectivo de 108 pretérminos de peso < 1.500 gramos y edad gestacional < 34 semanas. Se excluyeron a los prematuros afectados de enfermedad hemolítica o hemorrágica y/o fallecimiento durante los primeros días de vida. Fueron tratados 54 pacientes con rH-EPO (250 U/kg, subcutánea, 3 veces por semana) durante 6 semanas. Se añadió sulfato ferroso oral (4-6 mg/kg/día) y un complejo polivitamínico. RESULTADOS: < edad gestacional, peso, ferritina, hemoglobina y hematócrito al ingreso, número de extracciones y días con ventilación mecánica. El número de transfusiones por niño en el grupo sin rH-EPO fue de 1,46 ñ 1,38, frente a 0,69 ñ 1,19 en el tratado (p < 0,002). Un 63 por ciento de los niños tratados no precisaron ser transfundidos frente a un 29 por ciento del grupo control (p < 0,001). La hemoglobina media más baja alcanzada fue de 8,72 ñ 2,62 g/dl en el grupo sin tratamiento, frente a una hemoglobina de 9,7 ñ 2,08 g/dl en el que sí lo recibió. CONCLUSIÓN: La administración profiláctica de rH-EPO muestra una tendencia a disminuir el número de transfusiones en los prematuros de bajo peso, siendo claramente eficaz en los pretérminos estables con un peso superior a 1.000 gramos (AU)